+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Neurovascular Catheters Market by Type, Application, End-use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337485
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Neurovascular Catheters Market grew from USD 4.37 billion in 2023 to USD 4.90 billion in 2024. It is expected to continue growing at a CAGR of 12.01%, reaching USD 9.68 billion by 2030.

The neurovascular catheters market is pivotal within the healthcare domain, aiding in diagnosing and treating vascular diseases of the central nervous system. These catheters are vital in neuro-interventional procedures, such as embolization and thrombectomy, due to their flexibility, precision, and compatibility with advanced imaging techniques. The necessity of neurovascular catheters stems from the increasing prevalence of neurovascular disorders like aneurysms and strokes, coupled with the growing demand for minimally invasive surgical procedures. Primarily, hospitals, ambulatory surgical centers, and specialty clinics comprise the end-use sector, leveraging these tools to improve patient outcomes. Market growth is significantly influenced by advancements in technology, such as the development of tracking systems, and the rising geriatric population susceptible to neurological ailments. Government healthcare reforms and increasing healthcare expenditure further support this expansion. Key opportunities lie in emerging markets in Asia-Pacific and Latin America, where healthcare infrastructure is expanding. Recommendations include investing in R&D to innovate catheter materials and design and forming strategic partnerships to expand market reach. However, market limitations include stringent regulatory frameworks and high costs associated with advanced procedures and technologies that may hinder widespread adoption. Additionally, the risk of complications such as infection or vessel injury remains a challenging factor. Innovation should focus on biodegradable materials, enhanced drug delivery systems integrated within catheters, and real-time monitoring capabilities to improve efficacy and safety. Overall, the neurovascular catheters market is dynamic and competitive, characterized by constant innovation and a pressing need to balance cutting-edge technology with regulatory compliance and cost-effectiveness. Businesses poised to exploit these technologies will likely sustain competitive advantages and achieve substantial growth, provided they navigate the associated risks effectively.

Understanding Market Dynamics in the Neurovascular Catheters Market

The Neurovascular Catheters Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rapid shift to minimally invasive brain surgeries
    • Supportive government policies concerning health and creating awareness
    • Rising prevalence of neurological conditions
  • Market Restraints
    • Risk of catheter blockage
  • Market Opportunities
    • Technological development in neurovascular catheters
    • Ongoing advances in designs of catheters
  • Market Challenges
    • Limitation in terms of biocompatibility with neurovascular organs

Exploring Porter’s Five Forces for the Neurovascular Catheters Market

Porter’s Five Forces framework further strengthens the insights of the Neurovascular Catheters Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Neurovascular Catheters Market

External macro-environmental factors deeply influence the performance of the Neurovascular Catheters Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Neurovascular Catheters Market

The Neurovascular Catheters Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Neurovascular Catheters Market

The Neurovascular Catheters Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Neurovascular Catheters Market

The Neurovascular Catheters Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Catheters Market, highlighting leading vendors and their innovative profiles. These include Acandis GmbH, Access Vascular, Inc., Balt USA LLC, Biomerics LLC, ICU Medical, Inc., Imperative Care Inc., Integra Lifesciences Corporation, Johnson & Johnson Services, Inc., Medtronic Plc, Microvention Inc. by Terumo Corporation, Penumbra, Inc., Shape Memory Medical Inc., Spiegelberg Gmbh & Co. KG, Stryker Corporation, TE Connectivity, Teleflex Incorporated, and Zeus Industrial Products, Inc..

Market Segmentation & Coverage

This research report categorizes the Neurovascular Catheters Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Access Catheters
    • Balloon Catheters
    • Embolization Catheters
    • Microcatheters
  • Application
    • Arteriovenous Malformations
    • Brain Aneurysm
    • Embolic Stroke
  • End-use
    • Ambulatory Surgical Centers
    • Clinics
    • Diagnostic Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid shift to minimally invasive brain surgeries
5.1.1.2. Supportive government policies concerning health and creating awareness
5.1.1.3. Rising prevalence of neurological conditions
5.1.2. Restraints
5.1.2.1. Risk of catheter blockage
5.1.3. Opportunities
5.1.3.1. Technological development in neurovascular catheters
5.1.3.2. Ongoing advances in designs of catheters
5.1.4. Challenges
5.1.4.1. Limitation in terms of biocompatibility with neurovascular organs
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Neurovascular Catheters Market, by Type
6.1. Introduction
6.2. Access Catheters
6.3. Balloon Catheters
6.4. Embolization Catheters
6.5. Microcatheters
7. Neurovascular Catheters Market, by Application
7.1. Introduction
7.2. Arteriovenous Malformations
7.3. Brain Aneurysm
7.4. Embolic Stroke
8. Neurovascular Catheters Market, by End-use
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Clinics
8.4. Diagnostic Centers
8.5. Hospitals
9. Americas Neurovascular Catheters Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Neurovascular Catheters Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Neurovascular Catheters Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. NEUROVASCULAR CATHETERS MARKET RESEARCH PROCESS
FIGURE 2. NEUROVASCULAR CATHETERS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. NEUROVASCULAR CATHETERS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. NEUROVASCULAR CATHETERS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. NEUROVASCULAR CATHETERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. NEUROVASCULAR CATHETERS MARKET DYNAMICS
TABLE 7. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ACCESS CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIC STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 31. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 51. INDIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. INDIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. JAPAN NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. THAILAND NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. DENMARK NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. DENMARK NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. EGYPT NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. FINLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 103. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. NORWAY NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 115. POLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. POLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. POLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 118. QATAR NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. QATAR NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. TURKEY NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 148. NEUROVASCULAR CATHETERS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 149. NEUROVASCULAR CATHETERS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Neurovascular Catheters Market, which are profiled in this report, include:
  • Acandis GmbH
  • Access Vascular, Inc.
  • Balt USA LLC
  • Biomerics LLC
  • ICU Medical, Inc.
  • Imperative Care Inc.
  • Integra Lifesciences Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic Plc
  • Microvention Inc. by Terumo Corporation
  • Penumbra, Inc.
  • Shape Memory Medical Inc.
  • Spiegelberg Gmbh & Co. KG
  • Stryker Corporation
  • TE Connectivity
  • Teleflex Incorporated
  • Zeus Industrial Products, Inc.

Methodology

Loading
LOADING...

Table Information